Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study.
Xinyi HongShanhu QiuXia WuSizhen ChenXiaoxiang ChenBei ZhangAiqin HeYun XuJianqing WangYingchun GaoXizhong XuLi SunYang ZhangLibing XiangJundong ZhouQun GuanYanling ZhuHaiyan LiuHao XuYing ZhouBing-Wei ChenYang ShenPublished in: Drug design, development and therapy (2023)
In conclusion, Anlotinib holds promise in treating patients with advanced gynecological cancer including its disease-specific types, with reasonable efficacy and tolerable safety.